Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes

Soumaïla Camara1, Evariste Bouenizabila2, Michel P Hermans3

  • 1Ecole de Santé Publique, Faculté de Médecine, Université Libre de Bruxelles, Belgium.

Abstract

Insights

Achieving optimal diabetes control (LDL-C, SBP, HbA1c) is rare in T2DM patients. Those who meet all targets have better cardiometabolic health and fewer complications.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Type 2 Diabetes Mellitus (T2DM) management necessitates stringent control of LDL-C, SBP, and HbA1c to mitigate vascular complications.
  • This study investigates the attainment rates of these critical quality indicators in T2DM patients and identifies predictive pathophysiological traits.

Purpose of the Study:

  • To evaluate the proportion of T2DM patients achieving combined LDL-C, SBP, and HbA1c goals.
  • To identify cardiometabolic factors associated with achieving these critical quality indicators.

Main Methods:

  • Cross-sectional analysis of 1005 T2DM outpatients.
  • Assessed combined goal achievement: LDL-C<100 mg/dL, SBP<130 mmHg, HbA1c<7.0%.
  • Compared "triple-goal achievers" with "non-achievers" on various clinical and metabolic parameters.

Main Results:

  • Only 9% of T2DM patients achieved all three critical quality indicators.
  • Triple-goal achievers demonstrated shorter diabetes duration, lower visceral fat, better beta-cell function (HOMA B×S), and less metabolic syndrome.
  • Achievers had lower apoB, triglycerides, atherogenic dyslipidemia, microangiopathy, and 10-year CAD risk.

Conclusions:

  • T2DM patients achieving all critical quality indicators exhibit a less severe cardiometabolic phenotype.
  • These patients show less pronounced alterations in beta-cell function.
  • Attaining these goals is linked to reduced microvascular complications and lower cardiovascular risk.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K